Susceptibility to lung cancer may in part be attributable to inter-individual variability in metabolic activation or detoxification of tobacco carcinogens. The glutathione S-transferase M1 (GSTM1) genetic polymorphism has been extensively studied in this context; two recent meta-analyses of case-control studies suggested an association between GSTM1 deletion and lung cancer. At least 15 studies have been published after these overviews. We undertook a new meta-analysis to summarize the results of 43 published case-control studies including >18 000 individuals. A slight excess of risk of lung cancer for individuals with the GSTM1 null genotype was found (odds ratio (OR) ⍧ 1.17, 95% confidence interval (CI) 1.07-1.27). No evidence of publication bias was found (P ⍧ 0.4), however, it is not easy to estimate the extent of such bias and we cannot rule out some degree of publication bias in our results. A pooled analysis of the original data of about 9500 subjects involved in 21 case-control studies from the International CollabAbbreviations: CI, confidence interval; GST, glutathione S-transferase; OR, odds ratio.
Introduction
Numerous tobacco carcinogens are activated or detoxified by xenobiotic metabolizing enzymes (XMEs). Inherited differences in the XME-related metabolic capacity are potentially important sources of inter-individual variation in the susceptibility to development of smoking-related cancers. To date, five glutathione S-transferases (GSTs) classes have been described in humans, of which enzymes belonging to three of the classes, i.e. GST-M (µ) class, GST-P (π) class and GST-T (θ) class, are involved in the detoxification of electrophilic metabolites of several potential carcinogens present in tobacco smoke, including benzo[a]pyrene and other polycyclic aromatic hydrocarbons (1) . The homozygous deletion of GSTM1 gene (null genotype) results in a total lack of enzyme and is present iñ 50% of Caucasian and Asian populations, and 25% of African populations (Garte et al., personal communication). It is therefore conceivable that carriers of the null genotype are at increased risk of lung cancer because of a reduced ability to detoxify environmental carcinogens.
The association between GSTM1 polymorphism, determined by genotyping methods, and lung cancer has been investigated in numerous epidemiological studies. Two recent meta-analyses of case-control studies which had been published until May 1997 (2) and for the years 1985-1998 (3) , suggested an association between GSTM1 null genotype and lung cancer; the risks seemed to be higher among Asians and for squamous cell and small cell carcinomas (4) . Since these overviews, at least 15 additional case-control studies have examined the relationship of GSTM1 genotype and lung cancer. We have therefore undertaken a new meta-analysis to summarize the results of 43 published studies. Because the GSTM1 genotype is presumed to affect lung cancer risk by influencing detoxification of activated tobacco carcinogens, the potential modifying effect of GSTM1 genotype on the relationship between tobacco smoking and lung cancer is of particular interest. Differences in associations for the GSTM1 null genotype by level of smoking were investigated in some previous studies; however, the statistical power to detect them was generally limited. We therefore investigated the role of GSTM1 genotype as a modifier of the effect of smoking exposure on lung cancer risk in a pooled analysis of individual data from 21 separate studies provided to the International Collaborative Study on Genetic Susceptibility to Environmental Carcinogens (GSEC) (5).
Materials and methods

Data collection
A literature search for case-control studies on the association between lung cancer and GSTM1 genotype was conducted using citations in two previous review articles (2, 3) . For a given study, we retained the most recent results in the case of more than one publication on approximately the same data set. When results of a study were stratified by ethnicity, we treated data of each ethnic group as separate studies. A total of 20 genotype-based case-control studies were identified. We did not retain one study (6) because of outlying results [odds ratio (OR) ϭ 6.7, 95% confidence intervals (CI) 3.0-15.3].
A search using MEDLINE was conducted to identify additional studies published before February 2001, without restriction on language. The results of this search brought the total number of published case-control studies to 43, with a total of 7463 lung cancer patients and 10 789 control individuals (see Appendix for details of individual studies).
Furthermore, we used the original data of 21 case-control studies on GSTM1 genotype and lung cancer, with a total of 3940 lung cancer patients and 5515 controls, which were provided by the investigators to the GSEC study, a collaborative project investigating the relationships of several genetic polymorphisms and cancers at different sites (5) . Investigators who had previously published case-control studies up to June 2000 were identified through MEDLINE. They were contacted by letter and asked to provide published or unpublished original data on all subjects included in their study(s). The results were published (or partly published) for 17 of the 21 studies on lung cancer and GSTM1 genotype and unpublished for the four remaining studies. For some of the studies, the number of subjects or of genotypes tested provided to the GSEC database differed slightly from those in the published reports.
Statistical analyses
Crude ORs and their 95% CIs associated with GSTM1 null genotype were estimated for each individual study. Meta-analytic techniques that weight the logarithm of the OR of each study by a function of its variance were used to calculate a summary estimate. Both fixed-and random-effects models were used and results of the latter are presented in case of heterogeneity between studies, defined as Q-statistics with P Ͻ 0.05 (7) . Meta-analyses were performed on the total data set and separately for the major ethnic groups, and after restriction to studies involving population controls. Results of metaanalyses may be biased if not all available studies are included (8) . We assessed potential publication bias (tendency for authors to submit or of journals to accept preferentially papers reporting an association over papers reporting no association) by examining funnel plots (9) and using Egger's test (10) . This statistical test detects whether the intercept deviates significantly from zero in a regression of the standardized effect estimates against their precision.
Individual data of lung cancer patients and controls included in the GSEC database were used to investigate the potential modifying effect of GSTM1 genotype on the relationship between smoking and lung cancer, and to test if the association between GSTM1 and lung cancer varies with histology, ethnicity or gender. Individuals were categorized as never-versus eversmokers; for ever-smokers, smoking exposure was further categorized as Ͻ20, 20-39 and ജ40 pack-years (years smoked times the packs of cigarettes/day) according to the tertile distribution in the control population. Analyses were conducted using unconditional logistic regression models taking into account the potential confounding effects of age (in tertiles), gender, and center on the pooled data set, and after stratification by lung cancer histology, ethnicity and gender; however, the sample sizes were large enough on cross-classification to allow these analyses only for squamous cell carcinoma, small cell carcinoma and adenocarcinoma, and for Caucasian and Asian individuals. Individuals with the GSTM1 present genotype were used as reference category in each category of smoking exposure. Statistical analyses were performed using STATA software (version 6.0).
Results
The ethnicity of cases and controls was detailed in 40 of the studies; most of the subjects in the pooled data set were either Caucasians (55%) or Asians (25%) ( Table I ). Individual study results of lung cancer risk associated with GSTM1 null genotype are presented in Figure 1 . An OR above 1 was found in 31 studies, but the increase in risk was statistically significant in only five of them. The summary OR generated by all the 43 published case-control studies suggested a weak association between GSTM1 null genotype and lung cancer (OR ϭ 1.17, 95% CI 1.07-1.27), but the estimates lacked homogeneity (P ϭ 0.007) ( Table I ). Stratification by ethnicity showed lack of heterogeneity in the estimates for Caucasians (20 studies, P ϭ 0.5, summary OR ϭ 1.10, 95% CI 1.01-1.19) and heterogeneity for Asians (12 studies, P ϭ 0.001, summary OR ϭ 1.33, 95% CI 1.06-1.67). No significant associations were found in other ethnic groups (Table I) . We found no evidence of publication bias based on Begg's funnel plot ( Figure 2 ) and Egger's tests on all studies (P ϭ 0.4), or separately for Caucasian (P ϭ 0.8) or Asian (P ϭ 0.7) populations (funnel plots not shown). Additional analyses on 14 studies published in 1999-2000 and not included in the previous overviews yielded a OR ϭ 1.16 (95% CI 1.00-1.33); heterogeneity in the estimates was of borderline significance (P ϭ 0.056). Selected characteristics of the 21 case-control studies from the GSEC database used to assess the association between GSTM1 genotype and lung cancer across groups of individuals with different smoking exposures are shown in Table II . Substantial amounts of data were available for studies including population controls and for Caucasian individuals (78 and 77% of the pooled data set, respectively). Information on age was provided for 99% of lung cancer patients (mean age ranged from 54-69 years) and 89% of controls (mean age ranged from 36-66 years). Data on smoking status (ever/never) was available for 91% of cases and 82% of controls, and information (29) were removed from the present analysis.
1345 on pack-years was provided for the majority of ever-smokers (93% of cases and 86% of controls). Smoking was a matching criterion in some studies or was not available in other studies; we were therefore unable to properly examine the associations between lung cancer and smoking in the total database. Logistic regression analysis restricted to studies without selection on smoking habits and with available information on smoking (11, 12, (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) Analyses on the total set of 21 studies in the GSEC database revealed no evidence for increased risk of lung cancer among carriers of GSTM1 null genotype (age-, sex-and centeradjusted OR ϭ 1.08, 95% CI 0.98-1.18) overall or separately for Caucasians (OR ϭ 1.03, 95% CI 0.93-1.14) or Asians (OR ϭ 1.09, 95% CI 0.82-1.45) (Table III) . Risk estimates from the pooling of individual data were similar for published 47  95  94  30  423  94  63  59  7  13  179  100  100  100  61  259  100  72  100  45  14  342  100  96  100  49  710  100  66  100  23  15  163  91  100  70  34  493  29  47  0  -23  150  100  100  97  48  172  100  100  98  40  24  160  98  97  100  54  312  39  100  100  38  16  341  100  91  100  54  456  100  63  99  24  29 and 17  216  100  93  99  35  442  66  23  3  0  18  230  100  89  99  42  332  100  27  100  12  19  165  100  86  87  40  327  100  56  76  21  20  75  63  43  100  18  121  100  18  0  -21  247  100  100  97  40  254  100  82  95  24  48  117  97  92  95  40  119  95  79  97  29  25  242  100  50  100  16  95  100  2  100  0  54  23  100  100  100  93  28  96  100  93  63  22  297  100  86  100  26  423  100  73  100  11  Unpublished b  169  99  90  99  61  164  96  81  96  36  Unpublished c  201  67  87  0  -102  0  ---Unpublished d  49  88  95  98  44  72  0  ---Unpublished e  63  100  92  93  42  70  100  53  97  11 Studies (Table IV) did not produce any appreciable increase in risks for carriers of GSTM1 null genotype: OR ϭ 0.94 (95% CI 0.74-1.21) for smokers of ഛ20 pack-years, OR ϭ 1.21 (95% CI 0.97-1.50) for smokers of 20-39 pack-years, and OR ϭ 1.20 (95% CI 1.00-1.45) for smokers of ജ40 pack-years (Table IV) . Likewise, stratification by sex, histology (squamous cell, small cell or adenocarcinoma) or ethnicity (Caucasians or Asians) did not reveal differences in risks associated with GSTM1 genotypes (Table IV) .
Discussion
GSTM1 null genotype conferred a 1.17-fold statistically significant increased risk of lung cancer in our meta-analysis of 43 published case-control studies involving Ͼ18 000 subjects. Our findings are consistent with the summary meta-analysis ORs of 1.13 and 1.20 reported by Houlston (3) and Vineis et al. (4) , respectively. They also suggest that the association might be stronger among Asians. Results of meta-analyses may depend on control selection procedures; however, restriction of the analyses to studies with population controls did not materially alter the present observations on association between the GSTM1 genotype and lung cancer. Meta-analysis based on only published reports will yield biased results if publication bias is operating (8) . In the absence of publication bias, funnel plot will resemble a symmetrical inverted funnel. In our analyses, both the funnel plots and statistical tests, although not very powerful, suggest absence of substantial publication bias. However, it is not easy to estimate the extent of publication bias and we cannot rule out that such bias could explain the slight excess risk of lung cancer observed in our meta-analysis.
Lung cancer risk was not significantly associated with GSTM1 null genotype in our analyses of individual data of a subset of 21 case-control studies. Meta-analyses of published results and pooled analyses of original data have advantages and limitations. More valid and precise conclusions regarding a particular exposure-disease relation are expected in pooled analyses because of use of common definitions, coding, cutpoints for variables and adjustment for the same confounders. Given that adjustment for age, sex and center was included in the present pooled analysis, it is probable that our results, if anything, are only modestly confounded by these factors. However, other genetic factors (e.g. CYP1A1 genetic polymorphisms), not taken into account in our analyses, may confound the association between lung cancer and GSTM1 genotype. Errors in assigned GSTM1 genotype may also bias the risk estimates; as long as this misclassification is nondifferential with respect to case-control status, the bias is toward the null. Frequencies of GSTM1 null genotype in the controls of the major ethnic groups were consistent with that estimated in a very large control series (Garte et al., personal communication), which however comprises our controls. It seems also unlikely that the lack of association between GSTM1 polymorphism and lung cancer may be due to differential The large amount of available data on smoking-related variables in the GSEC database (~87% of all subjects) allowed us to study the potential modifying effect of GSTM1 genotype on the relationship between tobacco smoking and lung cancer. In the pooled analysis of 21 studies, we found no evidence of interaction between GSTM1 genotype and either smoking status or smoking consumption. Analyses of gene-environment interactions raise concerns about adequate statistical power. To date, most of the reported studies on lung cancer had limited power to detect interactions between GSTM1 polymorphism and smoking. In the present analyses, based on over 9000 individuals, we had 80% power to detect an OR for interaction of between 1.5 and 1.6, based on an OR of 10.0 for ever smoking, and an OR of 1.2 for having the GSTM1 null genotype (26) . Therefore, lack of differences in risks associated with GSTM1 genotypes across categories of smoking are likely not explained by insufficient power.
In the present study, GSTM1 genotype did not appear to interact with smoking; however, it is possible that genegene interactions (e.g. between different types of GSTs) and interactions between genes and other environmental factors may play a role. For instance, recent data from studies in China (27) and the US (28) suggest that dietary isothiocyanates may modify the effect of GSTM1, which catalyzes the rapid elimination of these beneficial compounds. Few of the published studies contain dietary information and thus we were not able to consider this potential diet-gene interaction.
